Meet Jose Alejandro Rauh-Hain, M.D.
Jose Alejandro Rauh-Hain, M.D., M.P.H.
Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery
About Dr. Jose Alejandro Rauh-Hain
Dr. Rauh-Hain is a Gynecologic Oncologist on staff at the University of Texas MD Anderson Cancer Center. He was born and raised in Mexico City, Mexico and received his medical degree from Universidad Panamericana School of Medicine. After graduating from medical school, Dr. Rauh-Hain accepted an opportunity to work as a research fellow at the Massachusetts General Hospital. He conducted basic science research in the laboratory and performed clinical studies looking for biomarkers for early detection of preeclampsia. Afterwards he was accepted in the combined Obstetrics and Gynecology Residency Program at the Massachusetts General Hospital and Brigham and Women's Hospital, Harvard Medical School. Following residency, he completed a fellowship in Gynecologic Oncology at the Massachusetts General Hospital, Harvard Medical School. He completed a Masters in Public Health (MPH) at the Harvard School of Public Health and a post-doctoral fellowship in the Program in Cancer Outcomes Research Training Program. He served as faculty member in the Division of Gynecologic Oncology the Massachusetts General Hospital and was an Assistant Professor at Harvard Medical School before joining the University of Texas MD Anderson Cancer Center. His interests include the surgical treatment of gynecologic malignancies and the management of rare gynecologic tumors. He is also interested in descriptive and intervention research studies conducted in real-world clinical settings that may possibly reveal the effectiveness of strategies to reduce well-documented disparities in gynecological cancer and improve care of young women with cancer.
Present Title & Affiliation
Primary Appointment
Associate Professor, Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, UT MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Associate Professor, Department of Health Services Research, Division of OVP, Cancer Prevention and Population Sciences, UT MD Anderson Cancer Center , Houston, TX
Clinical Interests
Ovarian cancer surgery and management
Endometrial cancer surgery and management
Cervical cancer surgery and management
Minimally invasive surgery
Pelvic reconstructive surgery
Fertility preservation for cancer patients
Health disparities among minority women
Rare gynecologic cancers
Clinical trial design
Education & Training
Degree-Granting Education
| 2017 | Harvard School of Public Health, Boston, MA, USA, MPH, Clinical Effectiveness Tract |
| 2004 | Universidad Panamericana, Mexico City, MEX, MD, Medicine |
Postgraduate Training
| 2012-2015 | Clinical Fellowship, Gynecologic Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA |
| 2008-2012 | Clinical Residency, Obstetrics and Gynecology, Brigham and Women’s Hospital and Massachusetts General Hospital, Harvard Medical School, Boston, MA |
| 2006-2008 | Research Fellowship, Massachusetts General Hospital, Harvard Medical School, Boston, MA |
Board Certifications
| 2016 | American Board of Obstetrics and Gynecology |
Experience & Service
Academic Appointments
Assistant Professor, Department of Gynecologic Oncology and Reproductive Medicine, Division of Gynecologic Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 2017 - 2017
Instructor, Department of Gynecologic Oncology and Reproductive Medicine, Division of Gynecologic Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, TX, 2015 - 2017
Administrative Appointments/Responsibilities
Co-Chair, Gynecologic Oncology Fellows/ Allied Health Research Network, Boston, MA, 2013 - 2014
Teaching Chief Resident, Brigham and Women’s Hospital and Massachusetts General Hospital, Harvard Medical School, Boston, MA, 2011 - 2012
Other Appointments/Responsibilities
Co-Director, Ovarian Cancer Working Group, Department of Gynecologic Oncology, MD Anderson Cancer Center, Houston, TX, 2020 - Present
Department Representative, Harris Health Cancer Committee, Houston, TX, 2019 - Present
Director, Department of Gynecologic Oncology LBJ research program, MD Anderson Cancer Center, Houston, TX, 2019 - Present
Clinical & Research Appointment, The Harris Health System - Lyndon B. Johnson Hospital, Houston, TX, 2019 - Present
Honors & Awards
| 2022 | FY22 Faculty Scholar Award, UT MD Anderson Cancer Center, Houston, Texas |
| 2015 | Francoise Hermann Foundation/Massachusetts General Hospital Cancer Center Award Program, Massachusetts General Hospital, Harvard Medical School |
| 2010 | Outstanding Teacher in Obstetrics and Gynecology, Harvard Medical School |
| 2010 | Resident Scholar Award, Association of Professors in Obstetrics and Gynecology |
| 2009 | Outstanding Teacher in Obstetrics and Gynecology, Harvard Medical School |
| 2008 | Outstanding Teacher in Obstetrics and Gynecology, Harvard Medical School |
| 2003 | Chief Sub-Intern, Hospital Escandon |
| 2003 | Honors Sub-Internship, Hospital Escandon |
| 2003 | Sub-Intern of the Year, Hospital Escandon |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Bercow A, Nitecki R, Brady PC, Rauh-Hain JA. Outcomes after Fertility-Sparing Surgery for Women with Ovarian Cancer: A Systematic Review of the Literature. J Minim Invasive Gynecol 28(3):527-536.e1, 2021. e-Pub 2020. PMID: 32861046.
- Nitecki R, Woodard T, Rauh-Hain JA. Fertility-Sparing Treatment for Early-Stage Cervical, Ovarian, and Endometrial Malignancies. Obstet Gynecol 136(6):1157-1169, 2020. PMID: 33156194.
- Nitecki R, Rauh-Hain JA, Melamed A, Scambia G, Pareja R, Coleman RL, Ramirez PT, Fagotti A. Laparoscopic cytoreduction After Neoadjuvant ChEmotherapy (LANCE). Int J Gynecol Cancer 30(9):1450-1454, 2020. e-Pub 2020. PMID: 32690591.
- Weaver DT, Raphel TJ, Melamed A, Rauh-Hain JA, Schorge JO, Knudsen AB, Pandharipande PV. Modeling treatment outcomes for patients with advanced ovarian cancer: Projected benefits of a test to optimize treatment selection. Gynecol Oncol 149(2):256-262, 2018. e-Pub 2018. PMID: 29486993.
- Rauh-Hain JA, Melamed A, Schaps D, Bregar AJ, Spencer R, Schorge JO, Rice LW, Del Carmen MG. Racial and ethnic disparities over time in the treatment and mortality of women with gynecological malignancies. Gynecol Oncol 149(1):4-11, 2018. PMID: 29605048.
- Melamed A, Fink G, Wright AA, Keating NL, Gockley AA, Del Carmen MG, Schorge JO, Rauh-Hain JA. Effect of adoption of neoadjuvant chemotherapy for advanced ovarian cancer on all cause mortality: quasi-experimental study. BMJ 360:j5463, 2018. e-Pub 2018. PMID: 29298771.
- Melamed A, Manning-Geist B, Bregar AJ, Diver EJ, Goodman A, Del Carmen MG, Schorge JO, Rauh-Hain JA. Associations between residual disease and survival in epithelial ovarian cancer by histologic type. Gynecol Oncol 147(2):250-256, 2017. e-Pub 2017. PMID: 28822556.
- Melamed A, Rauh-Hain JA, Schorge JO. Clinical outcomes research in gynecologic oncology. Gynecol Oncol 146(3):653-660, 2017. e-Pub 2017. PMID: 28651803.
- Melamed A, Rizzo AE, Nitecki R, Gockley AA, Bregar AJ, Schorge JO, Del Carmen MG, Rauh-Hain JA. All-Cause Mortality After Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer. Obstet Gynecol 130(1):71-79, 2017. PMID: 28594773.
- Bregar AJ, Melamed A, Diver E, Clemmer JT, Uppal S, Schorge JO, Rice LW, Del Carmen MG, Rauh-Hain JA. Minimally Invasive Staging Surgery in Women with Early-Stage Endometrial Cancer: Analysis of the National Cancer Data Base. Ann Surg Oncol 24(6):1677-1687, 2017. e-Pub 2017. PMID: 28074326.
- Melamed A, Nitecki R, Boruta DM, Del Carmen MG, Clark RM, Growdon WB, Goodman A, Schorge JO, Rauh-Hain JA. Laparoscopy Compared With Laparotomy for Debulking Ovarian Cancer After Neoadjuvant Chemotherapy. Obstet Gynecol 129(5):861-869, 2017. PMID: 28383367.
- Gockley A, Melamed A, Bregar AJ, Clemmer JT, Birrer M, Schorge JO, Del Carmen MG, Rauh-Hain JA. Outcomes of Women With High-Grade and Low-Grade Advanced-Stage Serous Epithelial Ovarian Cancer. Obstet Gynecol 129(3):439-447, 2017. PMID: 28178043.
- Uppal S, Chapman C, Spencer RJ, Jolly S, Maturen K, Rauh-Hain JA, delCarmen MG, Rice LW. Association of Hospital Volume With Racial and Ethnic Disparities in Locally Advanced Cervical Cancer Treatment. Obstet Gynecol 129(2):295-304, 2017. PMID: 28079775.
- Melamed A, Keating NL, Clemmer JT, Bregar AJ, Wright JD, Boruta DM, Schorge JO, Del Carmen MG, Rauh-Hain JA. Laparoscopic staging for apparent stage I epithelial ovarian cancer. Am J Obstet Gynecol 216(1):50.e1-50.e12, 2017. e-Pub 2016. PMID: 27567562.
- Dorney KM, Growdon WB, Clemmer J, Rauh-Hain JA, Hall TR, Diver E, Boruta D, Del Carmen MG, Goodman A, Schorge JO, Horowitz N, Clark RM. Patient, treatment and discharge factors associated with hospital readmission within 30days after surgery for vulvar cancer. Gynecol Oncol 144(1):136-139, 2017. e-Pub 2016. PMID: 27836203.
- Rauh-Hain JA, Melamed A, Wright A, Gockley A, Clemmer JT, Schorge JO, Del Carmen MG, Keating NL. Overall Survival Following Neoadjuvant Chemotherapy vs Primary Cytoreductive Surgery in Women With Epithelial Ovarian Cancer: Analysis of the National Cancer Database. JAMA Oncol 3(1):76-82, 2017. PMID: 27892998.
- Melamed A, Hinchcliff EM, Clemmer JT, Bregar AJ, Uppal S, Bostock I, Schorge JO, Del Carmen MG, Rauh-Hain JA. Trends in the use of neoadjuvant chemotherapy for advanced ovarian cancer in the United States. Gynecol Oncol 143(2):236-240, 2016. e-Pub 2016. PMID: 27612977.
- Del Carmen MG, Supko JG, Horick NK, Rauh-Hain JA, Clark RM, Campos SM, Krasner CN, Atkinson T, Birrer MJ. Phase 1 and 2 study of carboplatin and pralatrexate in patients with recurrent, platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer. Cancer 122(21):3297-3306, 2016. e-Pub 2016. PMID: 27421044.
- Penn CA, Morgan DM, Rice LW, Harris JA, Rauh-Hain JA, Uppal S. Timing of and Reasons for Unplanned 30-Day Readmission After Hysterectomy for Benign Disease. Obstet Gynecol 128(4):889-97, 2016. PMID: 27607868.
- Foley OW, Rauh-Hain JA, Clark RM, Goodman A, Growdon WB, Boruta DM, Schorge JO, Del Carmen MG. Intraoperative Radiation Therapy in the Management of Gynecologic Malignancies. Am J Clin Oncol 39(4):329-34, 2016. PMID: 24685883.
- Uppal S, Del Carmen MG, Rice LW, Reynolds RK, Jolly S, Bregar A, Abdelsattar ZM, Rauh-Hain JA. Variation in care in concurrent chemotherapy administration during radiation for locally advanced cervical cancer. Gynecol Oncol 142(2):286-92, 2016. e-Pub 2016. PMID: 27234144.
- Rauh-Hain JA, Birrer M, Del Carmen MG. Carcinosarcoma of the ovary, fallopian tube, and peritoneum: Prognostic factors and treatment modalities. Gynecol Oncol 142(2):248-54, 2016. e-Pub 2016. PMID: 27321238.
- Rauh-Hain JA, Gonzalez R, Bregar AJ, Clemmer J, Hernández-Blanquisett A, Clark RM, Schorge JO, Del Carmen MG. Patterns of care, predictors and outcomes of chemotherapy for ovarian carcinosarcoma: A National Cancer Database analysis. Gynecol Oncol 142(1):38-43, 2016. e-Pub 2016. PMID: 27107722.
- Davis M, Aviki E, Rauh-Hain JA, Worley M, Berkowitz R, Schorge J, Muto M, Clark Sisodia R, Horowitz N, Del Carmen M. Investigating the Impact of Body Mass Index on Intraperitoneal Chemotherapy Outcomes in Ovarian and Fallopian Tube Cancer. Int J Gynecol Cancer 26(6):1033-40, 2016. PMID: 27206282.
- Gockley AA, Rauh-Hain JA, Anders AM, Meyer LA, Clemmer J, Lu KH, Clark RM, Schorge JO, del Carmen MG. Patterns of Care, Predictors, and Outcomes of Adjuvant Therapy for Early- and Advanced-Stage Uterine Clear Cell Carcinoma: A Population-Based Analysis. Int J Gynecol Cancer 26(4):697-704, 2016. PMID: 26825834.
- Hinchcliff EM, Esselen KM, Watkins JC, Oduyebo T, Rauh-Hain JA, Del Carmen MG, Quade BJ, Muto MG. The Role of Endometrial Biopsy in the Preoperative Detection of Uterine Leiomyosarcoma. J Minim Invasive Gynecol 23(4):567-72, 2016. e-Pub 2016. PMID: 26851414.
- Uppal S, Penn C, Del Carmen MG, Rauh-Hain JA, Reynolds RK, Rice LW. Readmissions after major gynecologic oncology surgery. Gynecol Oncol 141(2):287-292, 2016. e-Pub 2016. PMID: 26927757.
- Hinchcliff E, Rauh-Hain JA, Clemmer JT, Diver E, Hall T, Stall J, Growdon W, Clark R, Schorge J. Racial disparities in survival in malignant germ cell tumors of the ovary. Gynecol Oncol 140(3):463-9, 2016. e-Pub 2016. PMID: 26773470.
- Rauh-Hain JA, Vargas RJ, Clemmer J, Clark RM, Bradford LS, Growdon WB, Goodman A, Boruta DM, Schorge JO, del Carmen MG. Mucinous Adenocarcinoma of the Endometrium Compared With Endometrioid Endometrial Cancer: A SEER Analysis. Am J Clin Oncol 39(1):43-8, 2016. PMID: 24390270.
- Oduyebo T, Hinchcliff E, Meserve EE, Seidman MA, Quade BJ, Rauh-Hain JA, George S, Nucci MR, del Carmen MG, Muto MG. Risk Factors for Occult Uterine Sarcoma Among Women Undergoing Minimally Invasive Gynecologic Surgery. J Minim Invasive Gynecol 23(1):34-9, 2016. e-Pub 2015. PMID: 26253281.
- Foley OW, Birrer N, Rauh-Hain JA, Clark RM, DiTavi E, Del Carmen MG. Effect of Educational Intervention on Cervical Cancer Prevention and Screening in Hispanic Women. J Community Health 40(6):1178-84, 2015. PMID: 26026277.
- Rauh-Hain JA, Pepin KJ, Meyer LA, Clemmer JT, Lu KH, Rice LW, Uppal S, Schorge JO, Del Carmen MG. Management for Elderly Women With Advanced-Stage, High-Grade Endometrial Cancer. Obstet Gynecol 126(6):1198-206, 2015. PMID: 26551187.
- Rauh-Hain JA, Starbuck KD, Meyer LA, Clemmer J, Schorge JO, Lu KH, Del Carmen MG. Patterns of care, predictors and outcomes of chemotherapy for uterine carcinosarcoma: a National Cancer Database analysis. Gynecol Oncol 139(1):84-9, 2015. e-Pub 2015. PMID: 26307402.
- Rauh-Hain JA, Diver E, Meyer LA, Clemmer J, Lu KH, Del Carmen MG, Schorge JO. Patterns of care, associations and outcomes of chemotherapy for uterine serous carcinoma: analysis of the National Cancer Database. Gynecol Oncol 139(1):77-83, 2015. e-Pub 2015. PMID: 26325526.
- Melamed A, Rauh-Hain JA, Clemmer JT, Diver EJ, Hall TR, Clark RM, Uppal S, Goodman A, Boruta DM. Changing Trends in Lymphadenectomy for Endometrioid Adenocarcinoma of the Endometrium. Obstet Gynecol 126(4):815-22, 2015. PMID: 26348192.
- Rauh-Hain JA, Connor SC, Clemmer JT, Foley OW, Clark RM, Hall TR, Boruta DM, Schorge JO, del Carmen MG. Trends in Treatment of Uterine Serous Cancer in the Medicare Population. Int J Gynecol Cancer 25(6):1023-30, 2015. PMID: 25914960.
- Ghezelayagh T, Rauh-Hain JA, Growdon WB. Comparing mortality of vaginal sarcoma, squamous cell carcinoma, and adenocarcinoma in the surveillance, epidemiology, and end results database. Obstet Gynecol 125(6):1353-61, 2015. PMID: 26000506.
- Rauh-Hain JA, Hariton E, Clemmer J, Clark RM, Hall T, Boruta DM, Schorge JO, Del Carmen MG. Incidence and effects on mortality of venous thromboembolism in elderly women with endometrial cancer. Obstet Gynecol 125(6):1362-70, 2015. PMID: 26000507.
- Rauh-Hain JA, Foley OW, Winograd D, Andrade C, Clark RM, Vargas RJ, Hinchcliff EM, Esselen KM, Horowitz NS, del Carmen MG. Clinical characteristics and outcomes of patients with stage I epithelial ovarian cancer compared with fallopian tube cancer. Am J Obstet Gynecol 212(5):600.e1-8, 2015. e-Pub 2014. PMID: 25514761.
- Aviki EM, Rauh-Hain JA, Clark RM, Hall TR, Berkowitz LR, Boruta DM, Growdon WB, Schorge JO, Goodman A. Gynecologic Oncologist as surgical consultant: intraoperative consultations during general gynecologic surgery as an important focus of gynecologic oncology training. Gynecol Oncol 137(1):93-7, 2015. e-Pub 2015. PMID: 25617772.
- Rauh-Hain JA, Buskwofie A, Clemmer J, Boruta DM, Schorge JO, del Carmen MG. Racial disparities in treatment of high-grade endometrial cancer in the Medicare population. Obstet Gynecol 125(4):843-51, 2015. PMID: 25751197.
- Foley OW, Rauh-Hain JA, Clemmer J, Clark RM, Hall T, Diver EJ, Schorge JO, del Carmen MG. Trends in the treatment of uterine leiomyosarcoma in the Medicare population. Int J Gynecol Cancer 25(3):453-8, 2015. PMID: 25628107.
- Linkov F, Edwards RP, Althouse A, Rauh-Hain JA, Del Carmen MG, Freese KE, Kelley JL, Olawaiye AB. Obesity, lymphadenectomy and survival outcomes in intermediate to high-risk, early-stage endometrial cancer patients. Future Oncol 11(4):607-15, 2015. PMID: 25686116.
- Gockley AA, Rauh-Hain JA, del Carmen MG. Uterine leiomyosarcoma: a review article. Int J Gynecol Cancer 24(9):1538-42, 2014. PMID: 25304676.
- Owusu-Darko S, Rauh-Hain JA, Horowitz NS, Goodman A, Schorge JO, Del Carmen MG. Comparison of outcomes in patients with early-stage mucinous endometrial cancer and those with endometrioid endometrial cancer, with and without adjuvant therapy. J Reprod Med 59(11-12):527-33, 2014. PMID: 25552123.
- Rauh-Hain JA, Goodman A, Boruta DM, Schorge JO, Horowitz NS, del Carmen MG. Endometrial stromal sarcoma: a clinicopathologic study of 29 patients. J Reprod Med 59(11-12):547-52, 2014. PMID: 25552126.
- Rauh-Hain JA, Hinchcliff EM, Oduyebo T, Worley MJ, Andrade CA, Schorge JO, George S, Muto MG, del Carmen MG. Clinical outcomes of women with recurrent or persistent uterine leiomyosarcoma. Int J Gynecol Cancer 24(8):1434-40, 2014. PMID: 25248114.
- George S, Barysauskas C, Serrano C, Oduyebo T, Rauh-Hain JA, Del Carmen MG, Demetri GD, Muto MG. Retrospective cohort study evaluating the impact of intraperitoneal morcellation on outcomes of localized uterine leiomyosarcoma. Cancer 120(20):3154-8, 2014. e-Pub 2014. PMID: 24923260.
- Worley MJ, Guseh SH, Rauh-Hain JA, Esselen KM, Muto MG, Feltmate CM, Berkowitz RS, Del Carmen MG, Schorge JO, Horowitz NS. What is the optimal treatment for obese patients with advanced ovarian carcinoma?. Am J Obstet Gynecol 211(3):231.e1-9, 2014. e-Pub 2014. PMID: 24704062.
- Eskander RN, Osann K, Dickson E, Holman LL, Rauh-Hain JA, Spoozak L, Wu E, Krill L, Fader AN, Tewari KS. Assessment of palliative care training in gynecologic oncology: a gynecologic oncology fellow research network study. Gynecol Oncol 134(2):379-84, 2014. e-Pub 2014. PMID: 24887355.
- Vargas R, Rauh-Hain JA, Clemmer J, Clark RM, Goodman A, Growdon WB, Schorge JO, Del Carmen MG, Horowitz NS, Boruta DM. Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: a SEER analysis. Gynecol Oncol 133(2):216-20, 2014. e-Pub 2014. PMID: 24548726.
- Bradford LS, Rauh-Hain JA, Clark RM, Groeneweg JW, Zhang L, Borger D, Zukerberg LR, Growdon WB, Foster R, Rueda BR. Assessing the efficacy of targeting the phosphatidylinositol 3-kinase/AKT/mTOR signaling pathway in endometrial cancer. Gynecol Oncol 133(2):346-52, 2014. e-Pub 2014. PMID: 24561032.
- Rauh-Hain JA, Clemmer J, Clark RM, Bradford LS, Growdon WB, Goodman A, Boruta DM, Dizon DS, Schorge JO, del Carmen MG. Management and outcomes for elderly women with vulvar cancer over time. BJOG 121(6):719-27; discussion 727, 2014. e-Pub 2014. PMID: 24621118.
- Davis M, Rauh-Hain JA, Andrade C, Boruta DM, Schorge JO, Horowitz NS, May T, del Carmen MG. Comparison of clinical outcomes of patients with clear cell and endometrioid ovarian cancer associated with endometriosis to papillary serous carcinoma of the ovary. Gynecol Oncol 132(3):760-6, 2014. e-Pub 2014. PMID: 24440832.
- Guseh SH, Rauh-Hain JA, Tambouret RH, Davis M, Clark RM, Boruta DM, Goodman A, Growdon WB, Schorge JO, del Carmen MG. Transitional cell carcinoma of the ovary: a case-control study. Gynecol Oncol 132(3):649-53, 2014. e-Pub 2014. PMID: 24462804.
- Oduyebo T, Rauh-Hain JA, Meserve EE, Seidman MA, Hinchcliff E, George S, Quade B, Nucci MR, Del Carmen MG, Muto MG. The value of re-exploration in patients with inadvertently morcellated uterine sarcoma. Gynecol Oncol 132(2):360-5, 2014. e-Pub 2013. PMID: 24296345.
- Rauh-Hain JA, Clemmer J, Clark RM, Bradford LS, Growdon WB, Goodman A, Boruta DM, Schorge JO, del Carmen MG. Racial disparities and changes in clinical characteristics and survival for vulvar cancer over time. Am J Obstet Gynecol 209(5):468.e1-468.e10, 2013. e-Pub 2013. PMID: 23891626.
- Rauh-Hain JA, Davis M, Clemmer J, Clark RM, Growdon WB, Goodman AK, Boruta DM, Schorge JO, del Carmen MG. Prognostic determinants in patients with uterine and ovarian clear cell carcinoma: a SEER analysis. Gynecol Oncol 131(2):404-9, 2013. e-Pub 2013. PMID: 24004647.
- Rauh-Hain JA, Diver EJ, Clemmer JT, Bradford LS, Clark RM, Growdon WB, Goodman AK, Boruta DM, Schorge JO, del Carmen MG. Carcinosarcoma of the ovary compared to papillary serous ovarian carcinoma: a SEER analysis. Gynecol Oncol 131(1):46-51, 2013. e-Pub 2013. PMID: 23906658.
- Rauh-Hain JA, Clemmer JT, Bradford LS, Clark RM, Growdon WB, Goodman A, Boruta DM, Schorge JO, del Carmen MG. Racial disparities in cervical cancer survival over time. Cancer 119(20):3644-52, 2013. e-Pub 2013. PMID: 23913530.
- Clark RM, Growdon WB, Wiechert A, Boruta D, Del Carmen M, Goodman AK, Bradford L, Rauh-Hain JA, Schorge JO. Patient, treatment and discharge factors associated with hospital readmission within 30 days after surgical cytoreduction for epithelial ovarian carcinoma. Gynecol Oncol 130(3):407-10, 2013. e-Pub 2013. PMID: 23747329.
- Rauh-Hain JA, del Carmen MG. Endometrial stromal sarcoma: a systematic review. Obstet Gynecol 122(3):676-83, 2013. PMID: 23921879.
- Rauh-Hain JA, Guseh SH, Esselen KM, Growdon WB, Schorge JO, Horowitz NS, Krasner CN, del Carmen MG, Birrer MJ, Dizon DS. Patterns of recurrence in patients treated with bevacizumab in the primary treatment of advanced epithelial ovarian cancer. Int J Gynecol Cancer 23(7):1219-25, 2013. PMID: 23975042.
- Barroilhet L, Yang J, Hasselblatt K, Paranal RM, Ng SK, Rauh-Hain JA, Welch WR, Bradner JE, Berkowitz RS, Ng SW. C-terminal binding protein-2 regulates response of epithelial ovarian cancer cells to histone deacetylase inhibitors. Oncogene 32(33):3896-903, 2013. e-Pub 2012. PMID: 22945647.
- Rauh-Hain JA, Oduyebo T, Diver EJ, Guseh SH, George S, Muto MG, del Carmen MG. Uterine leiomyosarcoma: an updated series. Int J Gynecol Cancer 23(6):1036-43, 2013. PMID: 23714705.
- Rauh-Hain JA, Shoni M, Schorge JO, Goodman A, Horowitz NS, del Carmen MG. Prognostic determinants in patients with uterine and ovarian carcinosarcoma. J Reprod Med 58(7-8):297-304, 2013. PMID: 23947079.
- Rauh-Hain JA, Nitschmann CC, Worley MJ, Bradford LS, Berkowitz RS, Schorge JO, Campos SM, del Carmen MG, Horowitz NS. Platinum resistance after neoadjuvant chemotherapy compared to primary surgery in patients with advanced epithelial ovarian carcinoma. Gynecol Oncol 129(1):63-8, 2013. e-Pub 2013. PMID: 23337490.
- Worley MJ, Guseh SH, Rauh-Hain JA, Williams KA, Muto MG, Feltmate CM, Berkowitz RS, Horowitz NS. Does neoadjuvant chemotherapy decrease the risk of hospital readmission following debulking surgery?. Gynecol Oncol 129(1):69-73, 2013. e-Pub 2013. PMID: 23375727.
- Worley MJ, Nitschmann CC, Shoni M, Rauh-Hain JA, Williams KA, Feltmate CM. Preoperative leukocytosis imposes an increased risk of recurrence and death among patients with nonendometrioid endometrial carcinoma. Int J Gynecol Cancer 23(2):312-7, 2013. PMID: 23358179.
- Foley OW, Rauh-Hain JA, del Carmen MG. The role of intraoperative radiation therapy in the management of recurrent and locally advanced gynecologic cancers. Int J Gynecol Cancer 23(1):9-15, 2013. PMID: 23187790.
- Worley MJ, Rauh-Hain JA, Sandberg EM, Muto MG. Venous thromboembolism prophylaxis for laparoscopic surgery: a survey of members of the Society of Gynecologic Oncology. Int J Gynecol Cancer 23(1):208-15, 2013. PMID: 23221603.
- Smith AL, Krivak TC, Scott EM, Rauh-Hain JA, Sukumvanich P, Olawaiye AB, Richard SD. Dual-console robotic surgery compared to laparoscopic surgery with respect to surgical outcomes in a gynecologic oncology fellowship program. Gynecol Oncol 126(3):432-6, 2012. e-Pub 2012. PMID: 22613352.
- Rodriguez N, Yang J, Hasselblatt K, Liu S, Zhou Y, Rauh-Hain JA, Ng SK, Choi PW, Fong WP, Agar NY, Welch WR, Berkowitz RS, Ng SW. Casein kinase I epsilon interacts with mitochondrial proteins for the growth and survival of human ovarian cancer cells. EMBO Mol Med 4(9):952-63, 2012. e-Pub 2012. PMID: 22707389.
- Worley MJ, Nitschmann CC, Shoni M, Vitonis AF, Rauh-Hain JA, Feltmate CM. The significance of preoperative leukocytosis in endometrial carcinoma. Gynecol Oncol 125(3):561-5, 2012. e-Pub 2012. PMID: 22465698.
- Rodriguez N, Rauh-Hain JA, Shoni M, Berkowitz RS, Muto MG, Feltmate C, Schorge JO, Del Carmen MG, Matulonis UA, Horowitz NS. Changes in serum CA-125 can predict optimal cytoreduction to no gross residual disease in patients with advanced stage ovarian cancer treated with neoadjuvant chemotherapy. Gynecol Oncol 125(2):362-6, 2012. e-Pub 2012. PMID: 22333992.
- Rauh-Hain JA, Winograd D, Growdon WB, Schorge JO, Goodman AK, Boruta DM, Berkowitz RS, Horowitz NS, Del Carmen MG. Prognostic determinants in patients with uterine and ovarian clear carcinoma. Gynecol Oncol 125(2):376-80, 2012. e-Pub 2012. PMID: 22366593.
- Rauh-Hain JA, Growdon WB, Braga A, Goldstein DP, Berkowitz RS. Gestational trophoblastic neoplasia in adolescents. J Reprod Med 57(5-6):237-42, 2012. PMID: 22696819.
- Rauh-Hain JA, Rodriguez N, Growdon WB, Goodman AK, Boruta DM, Horowitz NS, del Carmen MG, Schorge JO. Primary debulking surgery versus neoadjuvant chemotherapy in stage IV ovarian cancer. Ann Surg Oncol 19(3):959-65, 2012. e-Pub 2011. PMID: 21994038.
- Growdon WB, Rauh-Hain JA, Cordon A, Garrett L, Schorge JO, Goodman A, Boruta DM, Horowitz NS, del Carmen MG. Prognostic determinants in patients with stage I uterine papillary serous carcinoma: a 15-year multi-institutional review. Int J Gynecol Cancer 22(3):417-24, 2012. PMID: 22237383.
- Diver EJ, Rauh-Hain JA, Del Carmen MG. Total pelvic exenteration for gynecologic malignancies. Int J Surg Oncol 2012:693535, 2012. e-Pub 2012. PMID: 22720150.
- Olawaiye AB, Godoy HE, Shahzad MM, Rauh-Hain JA, Lele SB, Odunsi K. Comparison of outcomes in patients treated with multi-agent regiments of cisplatin, adriamycin, and VP-16 versus carboplatin and paclitaxel for advanced and recurrent endometrial cancer. Eur J Gynaecol Oncol 33(5):477-9, 2012. PMID: 23185791.
- Rauh-Hain JA, Growdon WB, Rodriguez N, Goodman AK, Boruta DM, Schorge JO, Horowitz NS, del Carmen MG. Carcinosarcoma of the ovary: a case-control study. Gynecol Oncol 121(3):477-81, 2011. e-Pub 2011. PMID: 21420726.
- Rauh-Hain JA, Laufer MR. Increased diagnostic accuracy of laparoscopy in endometriosis using indigo carmine: a new technique. Fertil Steril 95(3):1113-4, 2011. e-Pub 2011. PMID: 21227413.
- Rauh-Hain JA, Krivak TC, Del Carmen MG, Olawaiye AB. Ovarian cancer screening and early detection in the general population. Rev Obstet Gynecol 4(1):15-21, 2011. PMID: 21629494.
- Rauh-Hain JA, Growdon WB, Schorge JO, Goodman AK, Boruta DM, McCann C, Horowitz NS, del Carmen MG. Prognostic determinants in patients with stage IIIC and IV uterine papillary serous carcinoma. Gynecol Oncol 119(2):299-304, 2010. e-Pub 2010. PMID: 20691465.
- Rauh-Hain JA, Olawaiye AB, Munro M, Ko E, Alarcon IA, Del Carmen MG, Duska L. Role of computed tomography in the surgical management of patients with bowel obstruction secondary to recurrent ovarian carcinoma. Ann Surg Oncol 17(3):853-60, 2010. PMID: 20183913.
- Steinberg G, Lee C, Rauh-Hain JA, Ecker J, Khankin EV, Hsu CD, Cohen B, Rana S, Karumanchi SA, Thadhani R, Hacker MR, Lim KH. Early-pregnancy soluble Fas levels in idiopathic small-for-gestational-age pregnancies. Am J Obstet Gynecol 202(3):299.e1-7, 2010. PMID: 20207247.
- Rauh-Hain JA, del Carmen M, Horowitz NS, Alarcon IA, Ko E, Goodman AK, Olawaiye AB. Impact of bowel obstruction at the time of initial presentation in women with ovarian cancer. BJOG 117(1):32-8, 2010. PMID: 20002368.
- Rauh-Hain JA, Del Carmen MG. Treatment for advanced and recurrent endometrial carcinoma: combined modalities. Oncologist 15(8):852-61, 2010. e-Pub 2010. PMID: 20660059.
- Rauh-Hain JA, Costaaggini I, Olawaiye AB, Growdon WB, Horowitz NS, del Carmen MG. A comparison of outcome in patients with stage 1 clear cell and grade 3 endometrioid adenocarcinoma of the endometrium with and without adjuvant therapy. Eur J Gynaecol Oncol 31(3):284-7, 2010. PMID: 21077469.
- Watts L, Joseph N, Velazquez A, Gonzalez M, Munro E, Muzikansky A, Rauh-Hain JA, Del Carmen MG. Understanding barriers to cervical cancer screening among Hispanic women. Am J Obstet Gynecol 201(2):199.e1-8, 2009. PMID: 19646571.
- Rauh-Hain JA, Rana S, Tamez H, Wang A, Cohen B, Cohen A, Brown F, Ecker JL, Karumanchi SA, Thadhani R. Risk for developing gestational diabetes in women with twin pregnancies. J Matern Fetal Neonatal Med 22(4):293-9, 2009. PMID: 19340713.
- Watts LA, Joseph N, Wallace M, Rauh-Hain JA, Muzikansky A, Growdon WB, del Carmen MG. HPV vaccine: A comparison of attitudes and behavioral perspectives between Latino and non-Latino women. Gynecol Oncol 112(3):577-82, 2009. e-Pub 2009. PMID: 19150120.
- Rauh-Hain JA, Penson RT. Potential benefit of Sunitinib in recurrent and refractory ovarian clear cell adenocarcinoma. Int J Gynecol Cancer 18(5):934-6, 2008. e-Pub 2007. PMID: 18081793.
- Olawaiye AB, Rauh-Hain JA, Withiam-Leitch M, Rueda B, Goodman A, del Carmen MG. Utility of pre-operative serum CA-125 in the management of uterine papillary serous carcinoma. Gynecol Oncol 110(3):293-8, 2008. e-Pub 2008. PMID: 18644620.
- Gutiérrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Jüppner H, Wolf M. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359(6):584-92, 2008. PMID: 18687639.
- Rana S, Karumanchi SA, Levine RJ, Venkatesha S, Rauh-Hain JA, Tamez H, Thadhani R. Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia. Hypertension 50(1):137-42, 2007. e-Pub 2007. PMID: 17515455.
Invited Articles
- Strasser-Weippl K, Chavarri-Guerra Y, Villarreal-Garza C, Bychkovsky BL, Debiasi M, Liedke PE, Soto-Perez-de-Celis E, Dizon D, Cazap E, de Lima Lopes G, Touya D, Nunes JS, St Louis J, Vail C, Bukowski A, Ramos-Elias P, Unger-Saldaña K, Brandao DF, Ferreyra ME, Luciani S, Nogueira-Rodrigues A, de Carvalho Calabrich AF, Del Carmen MG, Rauh-Hain JA, Schmeler K, Sala R, Goss PE. Progress and remaining challenges for cancer control in Latin America and the Caribbean. Lancet Oncol 16(14):1405-38, 2015. PMID: 26522157.
- Bradford LS, Rauh-Hain JA, Schorge J, Birrer MJ, Dizon DS. Advances in the management of recurrent endometrial cancer. Am J Clin Oncol 38(2):206-12, 2015. PMID: 23764681.
- Rauh-Hain JA, Melamed A, Buskwofie A, Schorge JO. Adnexal mass in the postmenopausal patient. Clin Obstet Gynecol 58(1):53-65, 2015. PMID: 25565080.
- Foley OW, Rauh-Hain JA, del Carmen MG. Recurrent epithelial ovarian cancer: an update on treatment. Oncology (Williston Park) 27(4):288-94, 298, 2013. PMID: 23781692.
- Schorge JO, Rauh-Hain JA. Atypical glandular cells. Clin Obstet Gynecol 56(1):35-43, 2013. PMID: 23314725.
- Penson RT, Rauh-Hain JA, Horowitz NS.. Antiangiogenic Therapy and Ovarian Cancer. Current Women's Health Reviews. Current Women's Health Reviews 4(1):33-44, 2008.
Book Chapters
- Rauh-Hain JA, del Carmen, Dizon D, Birrer MJ.. Gynecologic Cancer. In: Skeel's Handbook of Cancer Therapy. 9. Wolters Kluwer: United States, 2016.
- Rauh-Hain JA, Dizon DS.. The Corpus: Epithelial tumors. In: Handbook for Principles and Practice of Gynecologic Oncology. 2nd. Wolters Kluwer: United States, 153-183, 2015.
- Rauh-Hain JA, del Carmen.. Carcinosarcoma of the Ovary. In: Uncommon Gynecologic Cancers. 1. Wiley-Blackwell: United States, 109-119, 2014.
- Rauh-Hain JA, Olawaiye AB, Boruta DM.. Uterine Clear Cell Carcinoma. In: Uncommon Gynecologic Cancers. 1. Wiley-Blackwell: United States, 186-194, 2014.
- Schmeler KM, Rauh-Hain JA, del Carmen.. Endometrial Stromal Sarcomas. In: Uncommon Gynecologic Cancers. 1. Wiley-Blackwell: United States, 205-215, 2014.
- Clark RM, Rauh-Hain JA, del Carmen.. Sarcomas of the Vulva and Vagina. In: Uncommon Gynecologic Cancers. 1. Wiley-Blackwell: United States, 236-243, 2014.
Letters to the Editor
- Melamed A, Rauh-Hain JA. In Reply. Obstet Gynecol 130: 470, 2017.
Grant & Contract Support
| Title: | First-line Treatment Trends and Costs in Women with Epithelial Ovarian Cancer / The Clinician-Teacher Development Award |
| Funding Source: | Massachusetts General Hospital Center for Diversity and Inclusion |
| Role: | Principal Investigator |
| Title: | First-line Treatment Trends and Costs in Women with Epithelial Ovarian Cancer / American Association of Obstetricians and Gynecologists Foundation Scholarship |
| Funding Source: | American Association of Obstetricians and Gynecologists Foundation Scholarship |
| Role: | Principal Investigator |
Patient Reviews
CV information above last modified August 28, 2024